A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity

Summary

This study is being done to look at the efficacy single and multiple ascending dose study investigating safety, tolerability, pharmacokinetics, food effect and target engagement in healthy adults including a single cohort in adults living with obesity. Participants will either get NNC6022-0004, (the treatment being tested) or Placebo (a treatment that has no active medicine in it) and which treatment participants get is decided by chance.

Timeline

Start

2026-07-06

Primary completion

2027-08-01

Completion

2027-08-01

Drugs

Indications